Mechanism of double-base lesion bypass catalyzed by a Y-family DNA polymerase

As a widely used anticancer drug, cis-diamminedichloroplatinum(II) (cisplatin) reacts with adjacent purine bases in DNA to form predominantly cis-[Pt(NH(3))(2){d(GpG)-N7(1),-N7(2)}] intrastrand cross-links. Drug resistance, one of the major limitations of cisplatin therapy, is partially due to the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Jessica A., Newmister, Sean A., Fiala, Kevin A., Suo, Zucai
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Nucleic Acid Enzymes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475632/
https://www.ncbi.nlm.nih.gov/pubmed/18499711
http://dx.doi.org/10.1093/nar/gkn309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475632/
https://www.ncbi.nlm.nih.gov/pubmed/18499711
http://dx.doi.org/10.1093/nar/gkn309

Ejemplares similares